Skip to content
AgingNexus
☰ Menu

Evidence brief · intervention

Stem-cell therapy

Synthesized from 10 indexed sources · 2026-07-26 MST · preview (no AI key)
Preview synthesis (deterministic, no AI key configured). Set a provider key to generate the full brief.

Synthesis (preview — no live AI key for the active provider):

Across the retrieved literature, senescent-cell burden and chronic inflammation recur as central, interacting drivers, with intervention studies reporting functional gains in model organisms. Key works: [1][2][3][4][5].

Set the active provider's API key to generate full model-written analysis.

Sources

  1. [1] Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
  2. [2] Bone Tissue Engineering: Recent Advances and Challenges
  3. [3] Mesenchymal stem cell perspective: cell biology to clinical progress
  4. [4] Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
  5. [5] Targeting cancer stem cell pathways for cancer therapy
  6. [6] Stem cells: past, present, and future
  7. [7] Immunomodulatory properties of mesenchymal stromal cells
  8. [8] Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC
  9. [9] Interplay of Skin Aging: Mitochondrial Stress and Ultraviolet Exposure.
  10. [10] A Rras2-BMPR2 feedback loop sustains osteogenesis and represents a therapeutic target for osteoporosis.
All Stem-cell therapy works → Intervention dossier →